Skip to main content

Lagarde Michel's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Dec 4, 2025

Accession no.
0000097745-25-000178
Filed
Dec 4, 2025
Trade date
Dec 2-3, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $36.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lagarde MichelCIK 0001518973Officer (Executive Vice President & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 2, 2025Common StockMOption exerciseAcquired+36,000$105.17+$3,786,12059,479.91Direct
Dec 2, 2025Common StockSSaleDisposed−30,000$581.92−$17,457,60029,479.91Direct
Dec 3, 2025Common StockMOption exerciseAcquired+68,000$105.17+$7,151,56097,479.91Direct
Dec 3, 2025Common StockSSaleDisposed−29,479$583.33−$17,195,985.0768,000.91Direct
Dec 3, 2025Common StockSSaleDisposed−2,521$584.11−$1,472,541.3165,479.91Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 2, 2025Common StockMOption exerciseDisposed−36,000$0.00$086,637Direct
Dec 3, 2025Common StockMOption exerciseDisposed−68,000$0.00$018,637Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)